Table 1 Comparison of sociodemographics and clinical features between patients who developed VTE against patients who did not develop VTE post-surgery
Variables | Non-VTE patients (n = 634) | VTE patients (n = 6) | P value |
|---|---|---|---|
Median age | 66 (range 42–79) | 64 (range 56–69) | |
Body mass index | |||
Underweight | 1 (0.2%) | 0 (0.0%) | 0.016 |
Normal | 159 (25.1%) | 0 (0.0%) | |
Overweight | 284 (44.8%) | 2 (33.3%) | |
Obese | 182 (28.7%) | 4 (66.7%) | |
Unknown | 8 (1.3%) | 0 (0.0%) | |
Operative time (min) | Mean 180 (130–246) | Mean 170 (160–200) | 0.621 |
Prostate gland size (gram on MRI) | Mean 40 (range 25–250) | Mean 56 (40–123) | 0.460 |
Clinical stage | |||
T1 | 2(0.4%) | 0 | 0.632 |
T2 | 599 (94.4%) | 4 | |
T3 | 33 (5.2%) | 2 | |
Gleason staging | |||
6 | 53 (8.4%) | 0 (0.0%) | 0.580 |
7 | 418 (65.9%) | 5 (83.3%) | |
8 | 61 (9.6) | 1 (16.7%) | |
9 | 95 (15.0%) | 0 (0.0%) | |
Unknown | 7 (1.1%) | 0 (0.0%) | |
Comorbidities | |||
< 2 | 220 (34.7%) | 1 (16.7%) | 0.325 |
≥ 2 | 414 (65.3%) | 5 (83.3%) | |
Previous VTE | |||
Yes | 16 (2.5%) | 1 (16.7%) | 0.055 |
No | 618 (97.5%) | 5 (83.3%) | |
Extended pelvic lymph node dissection | |||
Yes | 549 (86.6%) | 5 (83.3%) | 0.454 |
No | 47 (7.4%) | 0 (0.0%) | |
Unknown | 38 (6.0%) | 1 (16.7%) | |
Immediate postoperative complications | |||
Yes | 95 (15.0%) | 3 (50.0%) | 0.055 |
No | 500 (79.0%) | 3 (50.0%) | |
Unknown | 38 (6.0%) | 0 (0.0%) | |
Duration of hospital stay | |||
< 5 days | 471 (74.3%) | 3 (50.0%) | < 0.001 |
≥ 5 days | 126 (19.9%) | 3 (50.0%) | |
Unknown | 37 (5.8%) | 0 (0.0%) | |
Number of readmissions | |||
0 | 431 (68.0%) | 2 (33.3%) | 0.036 |
≥ 1 | 196 (30.9%) | 4 (66.7%) | |
Unknown | 7 (1.1%) | 0 (0.0%) | |
Living status | |||
Dead | 35 (5.5%) | 2 (33.3%) | 0.010 |
Alive | 599 (94.5%) | 4 (66.7%) | |